Skip to main content
ORMP logo

ORMP · Oramed Pharmaceuticals Inc. · Holdings

Track ORMP — free
$4.14 -0.01 (-0.24%) At close · Oct 21
Market Cap
$172.63M
Shares
41.60M
Volume · Oct 21 84.41K Avg daily vol (3M) 185.85K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 86
Total Value: $80,727,212
Total Shares: 16,785,680

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 84 13F filers
Top Holder
22.7%
Sep 2023 → Jun 2026 · range 22.7% – 42.3%
of institutional value
Top 5
66.8%
Sep 2023 → Jun 2026 · range 63.9% – 86.5%
of institutional value
Top 10
81.3%
Sep 2023 → Jun 2026 · range 77.0% – 94.0%
of institutional value
HHI
1,096
Sep 2023 → Jun 2026 · range 1,096 – 2,529
Broadly held

Who Holds ORMP

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 84 filers, like-for-like change +26.7%; actively managed books +4.9%; index-like books +2215.2%.

Holder type Share Filers Change
Registered adviser 36.9% 30 +70.4%
Exempt adviser 25.5% 5 -33.3%
Adviser 15.1% 3 +20.3%
Bank 5.7% 11 +155.8%
Benefit plan 0.8% 1 +627.2%
Non-US 0.3% 3 +73078.0%
Holding company 11.4% 5 +1623.5%
Broker-dealer 0.0% 0 —
Unknown 4.4% 26 +25.1%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-06-30 13F.

Conviction and Crowding

84 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
3
3.57% of filers hold it in their top 10
Mar 31, 2026: 3
Holders above 5%
1
median weight 0.000%
Mar 31, 2026: 2
Crowding
14.6%
of shares outstanding, 43rd percentile
Mar 31, 2026: 20.3%
Private-fund advisers
13.9%
of shares outstanding
Institutional ownership
41.0%
52.8% of the estimated free float
Top 10 holders
81.4%
of 13F shares, Herfindahl 0.110
Active holders
+4.9%
like-for-like share change of active filers
5% stakes on record
2
1 13D, 1 13G (0 institutional, 1 passive, 0 exempt)
How long holders have held it value-weighted 6.6 quarters
Under 1 year 47.3% 1 to 3 years 37.9% 3 years or more 14.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$3.26
estimated per share
Mar 31, 2026: $2.75
Quarter-end price
$4.81
implied by 13F values
Estimated gain or loss
+47.3%
price against the estimated cost
Estimated at a loss
0.181%
of costed 13F value

Estimated cost covers 57.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ORMP's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 IVZ Invesco Ltd. 4
2 STT State Street Corp 3
3 BRK-B Berkshire Hathaway Inc 5
4 PLTR Palantir Technologies Inc. 3
5 AMD Advanced Micro Devices Inc 4
6 TXN Texas Instruments Inc 3
7 CVX Chevron Corp 4
8 AXP American Express Co 3
9 ABBV AbbVie Inc. 4
10 LLY ELI LILLY & Co 4

Shareholder Targets

13F filers that own its peers but not ORMP, quarter ended Jun 30, 2026

Found through its holder-overlap peers: IVZ, STT, BRK-B, PLTR, AMD, TXN, CVX, AXP, ABBV, LLY, JNJ, UNH, JPM, NVDA, AMZN, AAPL, MSFT, GOOGL, PG, HD. 7,296 filers in all.

# Filer In peers
1 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $1,612,525,972,941 20 held
2 NORGES BANK Non-US, Index-like $342,570,333,098 20 held
3 Capital Research Global Investors Adviser, Diversified active $220,111,103,861 18 held
4 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Registered adviser, Index-like $189,865,085,554 20 held
5 Capital World Investors Adviser, Diversified active $169,509,476,477 16 held
6 Berkshire Hathaway Inc Insurer, Concentrated $168,982,846,466 4 held
7 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $137,786,840,367 20 held
8 Amundi Holding company, Index-like $135,762,433,674 20 held
9 FRANKLIN RESOURCES INC Adviser, Diversified active $124,549,077,134 20 held
10 LILLY ENDOWMENT INC Unknown, Unknown $108,400,867,760 1 held

Fund Ownership of ORMP by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 3.10% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.54% 223,367
Index ETFs 2.57% 1,068,153
Active ETFs 0.17% 71,390
Active funds 0.39% 161,852
Unclassified 0.08% 32,307
All registered funds 3.74% 1,557,069
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 87 of 87
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1176309 CUSIP 68403P203 13F (30d) 9 filings 9 filers Visit website Investor relations